Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists), Opioid receptors antagonists(Opioid receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2/3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC20H24ClNO4 |
InChIKeyRHBRMCOKKKZVRY-ITLPAZOVSA-N |
CAS Registry16676-29-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Facial Pain | Phase 3 | US | 01 Mar 2014 | |
Neuralgia | Phase 3 | US | 01 Mar 2014 | |
Trigeminal Neuralgia | Phase 3 | US | 01 Mar 2014 | |
Low Back Pain | Phase 3 | US | 01 Jul 2011 | |
Neck Pain | Phase 3 | US | 01 Jul 2011 |